BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31396568)

  • 21. Improved Mycobacterium tuberculosis clearance after the restoration of IFN-γ
    Kamboj D; Gupta P; Basil MV; Mohan A; Guleria R; Bhatnagar A; Mehta G; Kumar P; Saurabh A; Deepak R; Thakral D; Misra P; Tandon R; Gupta UD; Mitra DK
    Eur J Immunol; 2020 May; 50(5):736-747. PubMed ID: 32113187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral blood gamma interferon release assays predict lung responses and Mycobacterium tuberculosis disease outcome in mice.
    Beamer GL; Flaherty DK; Vesosky B; Turner J
    Clin Vaccine Immunol; 2008 Mar; 15(3):474-83. PubMed ID: 18184822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucosal boosting of H56:CAF01 immunization promotes lung-localized T cells and an accelerated pulmonary response to Mycobacterium tuberculosis infection without enhancing vaccine protection.
    Woodworth JS; Christensen D; Cassidy JP; Agger EM; Mortensen R; Andersen P
    Mucosal Immunol; 2019 May; 12(3):816-826. PubMed ID: 30760832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subpopulation Structure of IFNγ-Producing T Lymphocytes in Patients with Pulmonary Tuberculosis.
    Kononova TE; Urazova OI; Novitskii VV; Esimova IE; Churina EG
    Bull Exp Biol Med; 2018 Jul; 165(3):311-314. PubMed ID: 30003413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary mucosal immunity mediated through CpG provides adequate protection against pulmonary Mycobacterium tuberculosis infection in the mouse model. A role for type I interferon.
    Troy A; Esparza-Gonzalez SC; Bartek A; Creissen E; Izzo L; Izzo AA
    Tuberculosis (Edinb); 2020 Jul; 123():101949. PubMed ID: 32741537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of
    Xiong K; Niu J; Zheng R; Liu Z; Song Y; Wang L; Zhu C; Fan L
    J Immunol Res; 2021; 2021():6625855. PubMed ID: 33628846
    [No Abstract]   [Full Text] [Related]  

  • 27. γ-herpesvirus latency attenuates Mycobacterium tuberculosis infection in mice.
    Miller HE; Johnson KE; Tarakanova VL; Robinson RT
    Tuberculosis (Edinb); 2019 May; 116():56-60. PubMed ID: 31153519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient 5-OP-RU-Induced Enrichment of Mucosa-Associated Invariant T Cells in the Murine Lung Does Not Enhance Control of Aerosol Mycobacterium tuberculosis Infection.
    Vorkas CK; Levy O; Skular M; Li K; Aubé J; Glickman MS
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33077620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressed induction of mycobacterial antigen-specific Th1-type CD4+ T cells in the lung after pulmonary mycobacterial infection.
    Yahagi A; Umemura M; Tamura T; Kariyone A; Begum MD; Kawakami K; Okamoto Y; Hamada S; Oshiro K; Kohama H; Arakawa T; Ohara N; Takatsu K; Matsuzaki G
    Int Immunol; 2010 Apr; 22(4):307-18. PubMed ID: 20167585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suboptimal Antigen Presentation Contributes to Virulence of Mycobacterium tuberculosis In Vivo.
    Grace PS; Ernst JD
    J Immunol; 2016 Jan; 196(1):357-64. PubMed ID: 26573837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary Mycobacterium tuberculosis control associates with CXCR3- and CCR6-expressing antigen-specific Th1 and Th17 cell recruitment.
    Shanmugasundaram U; Bucsan AN; Ganatra SR; Ibegbu C; Quezada M; Blair RV; Alvarez X; Velu V; Kaushal D; Rengarajan J
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32554933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation.
    Ordway D; Henao-Tamayo M; Harton M; Palanisamy G; Troudt J; Shanley C; Basaraba RJ; Orme IM
    J Immunol; 2007 Jul; 179(1):522-31. PubMed ID: 17579073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultra low dose aerosol challenge with Mycobacterium tuberculosis leads to divergent outcomes in rhesus and cynomolgus macaques.
    Sharpe S; White A; Gleeson F; McIntyre A; Smyth D; Clark S; Sarfas C; Laddy D; Rayner E; Hall G; Williams A; Dennis M
    Tuberculosis (Edinb); 2016 Jan; 96():1-12. PubMed ID: 26786648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection.
    Tonby K; Wergeland I; Lieske NV; Kvale D; Tasken K; Dyrhol-Riise AM
    BMC Infect Dis; 2016 Oct; 16(1):599. PubMed ID: 27776487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virulent but not avirulent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide Synthase 2-independent defense in mice.
    Jung YJ; LaCourse R; Ryan L; North RJ
    J Exp Med; 2002 Oct; 196(7):991-8. PubMed ID: 12370260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Manipulation of the Lipid Mediator Metabolism as Adjunct Host-Directed Therapy in Tuberculosis.
    Nienaber A; Hayford FEA; Variava E; Martinson N; Malan L
    Front Immunol; 2021; 12():623941. PubMed ID: 33777003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Th22 response induced by Mycobacterium tuberculosis strains is closely related to severity of pulmonary lesions and bacillary load in patients with multi-drug-resistant tuberculosis.
    Imperiale BR; García A; Minotti A; González Montaner P; Moracho L; Morcillo NS; Palmero DJ; Sasiain MDC; de la Barrera S
    Clin Exp Immunol; 2021 Feb; 203(2):267-280. PubMed ID: 33128773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis.
    Mzinza DT; Sloan DJ; Jambo KC; Shani D; Kamdolozi M; Wilkinson KA; Wilkinson RJ; Davies GR; Heyderman RS; Mwandumba HC
    Tuberculosis (Edinb); 2015 Jul; 95(4):463-9. PubMed ID: 26051653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis.
    Maglione PJ; Xu J; Chan J
    J Immunol; 2007 Jun; 178(11):7222-34. PubMed ID: 17513771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host genetic background affects regulatory T-cell activity that influences the magnitude of cellular immune response against Mycobacterium tuberculosis.
    Paula MO; Fonseca DM; Wowk PF; Gembre AF; Fedatto PF; Sérgio CA; Silva CL; Bonato VL
    Immunol Cell Biol; 2011 May; 89(4):526-34. PubMed ID: 20956987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.